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Although inorganic arsenic (iAs) is a well-
known human carcinogen recognized by the
World Health Organization (2001) and the
International Agency for Research on Cancer
(1987), the mechanism of carcinogenicity are
not clear. Because of signiﬁcant differences in
arsenic (As) metabolism between experimental
animals and humans, the use of animal models
to evaluate the carcinogenic effects iAs has not
been established successfully (Goering et al.
1999). For decades, As has been considered a
nongenotoxic carcinogen because it is only
weakly active or, more often, completely
inactive in bacterial and mammalian cell muta-
tion assays (Hei and Filipic 2004). Recently,
increasing evidence has shown that As is a
strong, dose-dependent gene and chromoso-
mal mutagen that is capable of inducing
mostly multilocus deletions (Hei et al. 1998).
Experiments in mammalian cells have also
shown that this induction was significantly
reduced in the presence of antioxidant
enzymes (Liu et al. 2002).
As early as 1976, villagers from Guizhou
province in southwestern China were reported
to be suffering severe symptoms of arsenicosis
(Zhou et al. 1993), which was attributed to
exposure to high levels of As in food, especially
in corn and chili peppers, and to a lesser extent
by breathing As-laden air (Finkelman et al.
2003). Villagers mined local low-grade As-
containing coal from abundant, small local coal
pits, with As-coal concentrations mostly in the
range of hundreds of milligrams per kilogram
(Finkelman et al. 1999; Zheng et al. 1999).
Corn and chili peppers were dried over unven-
tilated indoor stoves used for every day cooking
and for heating during the winter months.
Repeated surveys of As-coal and medical exami-
nations have identified nine towns in four
counties in southwest Guizhou province as
having high levels of As in food and air (Zhang
et al. 2000a). Approximately 200,000 people
within the four counties were at risk of expo-
sure to high levels of As; 3,000 cases of arseni-
cosis were diagnosed in the late 1990s, with
approximately 2,000 of these cases in Xinren
county alone (Liu et al. 2002). Over the years,
various measures adopted by local govern-
ments, such as shutting down the coal pits con-
taining high levels of As and installation of
ventilated stoves, have been only minimally
effective until a health education campaign was
implemented in 2005 (An et al. 2005). 
New cases of arsenicosis have been identi-
ﬁed each year since 1990, although there was
evidence of reduction in exposure as early as
1998. Between 1998 and 2004, collected coal
samples had As concentrations of 92–816
mg/kg (Huang et al. 2002). The average con-
centration in indoor air during that time was
0.087 ± 0.045 mg/m3 (n = 22), which is lower
than that in indoor air in 1991 [0.46 ± 0.30
mg/m3 (n = 18); Zhang et al. 2000a; Zhou
et al.1993]. Urinary As concentrations declined
from 130.6 ± 121.2 µg/L (n = 167) in 1998
to 97.0 ± 76.1 µg/L (n = 43) in 2004. This
ﬁnding coincided with the decrease of As con-
centrations in indoor air. In the exposed popu-
lation, skin lesions were common. Other
damage included lung dysfunction, neuro-
pathy, and nephrotoxicity. The prevalence of
hepatomegaly was 20%. Approximately 200
people have died from the effects of the most
severe As poisoning, which included liver cir-
rhosis, ascites, and liver and skin cancers.
Treatment of individuals who have arsenicosis
was difﬁcult because of a long exposure time of
more than 30 years (Zhou et al.1993) and the
high level of As exposure in the population.
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BACKGROUND: Inorganic arsenic (iAs) is a well-known human carcinogen recognized by the World
Health Organization and the International Agency for Research on Cancer. Currently, most iAs
studies in populations are concerned with drinking water and occupational arsenicosis. In Guizhou
province, arsenicosis caused by the burning of coal in unventilated indoor stoves is an unusual type
of exposure. Because the poisoning mechanism involved in arsenicosis is as yet unknown and no
effective therapy exists, progress has been slow on the prevention and therapy of arsenicosis. 
OBJECTIVES: We examined the relationship between arsenic (As) exposure from the burning of coal
in unventilated indoor stoves and genetic damage in humans, using cellular and molecular indices.
We selected villagers from Jiaole township, Guizhou province, China, who had been exposed to mil-
ligram levels of As daily via food and air contaminated by the burning of As-containing coal in
unventilated indoor stoves. 
RESULTS: The As-exposed subjects from Jiaole were divided into four groups according to skin lesion
symptoms: nonpatients, mild, intermediate, and severe arsenicosis. Another 53 villagers from a town
12 km from Jiaole were recruited as the external control group. In the four groups of exposed subjects,
As concentrations in urine and hair were 76–145 µg/L and 5.4–7.9 µg/g, respectively. These values
were higher than those in the external control group, which had As concentrations of 46 µg/L for
urine and 1.6 µg/g for hair. We measured sister chromatid exchange and chromosomal aberrations to
determine human chromosome damage, and for DNA damage, we measured DNA single-strand
breaks and DNA–protein cross-links. All measurements were higher in the four exposed groups com-
pared with the external control group. DNA repair was impaired by As exposure, as indicated by the
mRNA of O-6-methylguanine-DNA methyltransferase (MGMT), X-ray repair complementing defec-
tive repair in Chinese hamster cells 1 (XRCC1), and, to a lesser extent, by the mis-match repair gene
hMSH2 mRNA. The expression of mutant-type p53 increased with aggravation of arsenicosis symp-
toms, whereas the expression of p16-INK4(p16) decreased. p53 mutated at a frequency of 30–17% in
the carcinoma (n = 10) and precarcinoma (n = 12) groups. No mutation was found in p16, although
deletion was evident. Deletion rates were 8.7% (n = 23) and 38.9% (n = 18) in noncarcinoma and
carcinoma groups, respectively.
CONCLUSIONS: The results showed that long-term As exposure may be associated with damage of chro-
mosomes and DNA, gene mutations, gene deletions, and alterations of DNA synthesis and repair ability. 
KEY WORDS: arsenic, coal, genetic damage, toxicity. Environ Health Perspect 115:653–658 (2007).
doi:10.1289/ehp.9272 available via http://dx.doi.org/ [Online 9 January 2007]In this article, we report the results of a
series of investigations between 1998 and
2004, which included a large number of indi-
viduals with arsenicosis. To look for cellular
and molecular biomarkers of exposure, we col-
lected blood and skin samples from villagers
who had been exposed to As. We analyzed the
effects of As exposure on chromosome and
DNA damage, DNA synthesis and repair, and
tumor suppressor gene mutations. One of our
goals was to identify molecular biomarkers for
early diagnosis that may be applicable to popu-
lations exposed to much lower levels of As,
usually found in drinking water. 
Materials and Methods
Subjects. We consulted a database maintained
by the Guizhou Provincial Ofﬁce of Endemic
Disease to identify populations exposed to As
(Yang et al. 1998). All subjects in our study
resided in Jiaole township in Xinren county and
gave informed consent. Our team examined the
target population in 1998, with a total of 184
villagers who had been exposed to As agreeing
to participate in our study. Arsenicosis symp-
toms were categorized based on the degree of
symptoms: nonpatient (n = 19), mild (n = 49),
intermediate (n = 54), and severe (n = 62).
Symptoms were classified according to the
Chinese National Arsenicosis Diagnosis
Standard protocol (Yu et al. 2007). Two control
groups were included in this study. First, non-
patients (n = 19), deﬁned as individuals showing
no symptoms of arsenicosis, from Jiaole, were
designated the internal control group. The sec-
ond, designated the external control group,
comprised 53 villagers from Ma Jiatun township
(approximately 12 km from Jiaole) who did not
use coal containing high levels of As (Table 1). 
Biological samples. Blood and skin samples
were collected each year from 1998 to 2001
from villagers burning As-containing coal in
unventilated indoor stoves. Biosamples were
collected from the same villagers at each collec-
tion time; however, we could not always collect
samples from all subjects at each collection
time, which resulted in missing data.
In 1998 we obtained 193 blood samples
(external, n = 25; internal, n = 13; mild, n = 44;
intermediate, n = 49; severe, n = 62) in which
to study cellular chromosome damage
(Table 1). In the same year, skin samples were
collected from 70 subjects who were treated
surgically to alleviate pain related to arsenicosis.
These samples were used to measure of p53 and
p16-INK4 (p16) gene expression (Table 2). In
1999 we obtained a second batch of blood sam-
ples from 156 patients, 19 internal controls,
and 41 external controls in which to measure
DNA damage (Table 1). In 2001 a third batch
of blood samples was collected from 70 subjects
for analysis of p53 and p16 mutations
(Table 2). Also, in 2001, a second batch of skin
samples from 61 subjects who had undergone
surgery was obtained for DNA gene repair
study (Table 3). On the basis of dermal pathol-
ogy, the subjects from 2001 study were catego-
rized into four groups: group A, general
pathological changes (hyperplasia) with 22 sub-
jects belonging to mild (n = 8), moderate (n =
7), severe (n = 7) arsenicosis groups; group B,
hyperkeratosis with 22 subject belonging to
mild (n = 3), moderate (n = 7), and severe (n =
12) arsenicosis group; group C, precancerous
lesion with 12 subjects drawn from moderate
(n = 5) and severe (n = 7) arsenicosis groups;
and ﬁnally, group D, cancerous lesion with 18
subjects including squamous carcinoma, basal
cell carcinoma, and Bowen disease from mild
(n = 1), moderate (n = 3), and severe (n = 14)
arsenicosis groups. 
Urine samples were collected in acid-washed
plastic containers. Concentrated hydrochloric
acid (1 mL HCl to 100 mL urine) was added
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Table 1. Chromosome and DNA damage [mean ± SD (n)] in 184 villagers from Jiaole township (internal control and exposed groups) compared with 53 villagers
from Ma Jiatun township (external control).
DNA damage
As concentration (mean ± SD) Chromosome damage DS DPC  UDS  DNA  comet 
Group Urinary (µg/L) Hair (µg/g) SCE CA (%) MN (‰) (cpm) (cpm/µg DNA) (cpm) length (µm)
External control  45.6 ± 15.7 (53) 1.6 ± 1.2 (45) 3.0 ± 0.9 (23) 6.1 ± 2.3 (19) 1.5 ± 0.8 (25) 1,153 ± 710 (39) 943 ± 181 (40) 515 ± 196 (33) 8.6 ± 4.1 (41)
Internal control  76.3 ± 40.8a (16) 5.4 ± 4.9a (16) 3.8 ± 0.8a (10) 10.8 ± 6.0 (13) 1.8 ± 1.1 (12) 254 ± 113a (12) 1,229 ± 336a (11) 611 ± 362 (12) 13.8 ± 8.8b (19)
Mild 121.1 ± 110.3a,d (45) 6.7 ± 6.1a (46) 4.1 ± 1.3a (16) 15.1 ± 6.8a (43) 1.9 ± 1.3 (44) 315 ± 197a (19) 1,611 ± 476a (21) 687 ± 387b (21) 19.5 ± 6.7a,d (40)
Intermediate 140.2 ± 135.5a,d (51) 7.5 ± 7.0a (48) 4.6 ± 1.0a (40) 15.6 ± 9.1a (35) 1.8 ± 1.1 (49) 299.2 ± 255.2a (31) 2,130 ± 776a,c,f (25) 744 ± 507b (29) 30.1 ± 12.6a,c (54)
Severe 145.2 ± 128.5a,d (55) 7.9 ± 7.8a (62) 4.8 ± 1.1a,d (56) 17.2 ± 12.4a (59) 2.4 ± 1.4a,d,f,g (62) 213 ± 132a (39) 2,737 ± 1,017a,c,e,g (40) 782 ± 440b (38) 38.2 ± 14.4a,c (62)
Abbreviations: CA, chromosome aberration; DPC, DNA–protein cross-link; DS, spontaneous DNA synthesis; MN, micronucleus; n = number of subjects in each group; SCE, sister chromatid exchange;
UDS, unscheduled DNA synthesis.
aSigniﬁcantly different compared with the external control group (p < 0.01 using ANOVA). bSigniﬁcantly different compared with the external control group (p < 0.05 using ANOVA). cSigniﬁcantly differ-
ent compared to the internal control group (p < 0.01 using ANOVA). dSigniﬁcantly different compared with the internal control group (p < 0.05 using ANOVA). eSigniﬁcantly different compared with the
mild group (p < 0.01 using ANOVA). fSigniﬁcantly different compared with mild group (p < 0.05 using ANOVA). gSigniﬁcantly different compared with the intermediate group (p < 0.05 using ANOVA).
Table 2. Expressions of P53 and P16 proteins and p53 gene mutations in 70 villagers from Jiaole township.
P53 P16
As concentration (mean ± SD) Protein positive rate Gene mutation frequency  Protein positive rate
Group n Urinary (µg/L) Hair (µg/g) [positive/total (%)] [mutation/total (%)] [positive/total (%)]
Common pathological changes 22 134.0 ± 49.3 8.1 ± 6.5 3/18 (17) 0/22 (0) 15/19 (79)
Hyperkeratosis 22 146.1 ± 89.4 8.9 ± 4.8 7/21 (33) 0/16 (0) 15/22 (68)
Precarcinoma 12 146.2 ± 51.1 9.6 ± 5.3 8/11 (73)a,b 2/12 (17)a,b 4/11 (36)a
Carcinoma 18 169.8 ± 134.9 10.5 ± 9.4 16/18 (89)c,d 3/10e (30)a,b 6/18 (33)b,c
n = number of subjects in each group. 
ap < 0.05 compared with common pathological changes group using the chi-square test. bp < 0.05 compared with hyperkeratosis group using the chi-square test. cp < 0.01 compared
with common pathological changes group using the chi-square test. dp < 0.01 compared with hyperkeratosis group using the chi-square test. eTwo examples are silent mutations in
three mutation samples. 
Table 3. Comparison of the expression of DNA repair genes in 61 villagers with different skin lesion symptoms from Jiaole township, XinRen county, Guizhou province, China.
DNA repair genes [no. (%)]
As concentration (mean ± SD)  MGMT  XRCC1 hMSH2
Group n Urinary (µg/L) Hair (µg/g) Positive/total Mutation/total Positive/total
Common pathological changes 22 144.7 ± 56.5 9.9 ± 5.0 16/22 (72.7) 17/22 (77.3) 16/22 (72.7)
Hyperkeratosis 16 156.0 ± 70.7 11.0 ± 5.0 11/16 (68.8) 10/16 (62.5) 12/16 (75.0)
Precarcinoma 12 164.9 ± 64.4 11.5 ± 5.4 5/12 (41.7) 5/12 (41.7) 8/12 (66.7)
Carcinoma 11 169.5 ± 75.3 12.0 ± 5.1 2/11 (18.2)a,b 3/11 (27.3)a 4/11 (36.4)
n = number of subjects in each group.
ap < 0.01 compared with common pathological changes group using the chi-square test. bp < 0.05 compared with hyperkeratosis group using the chi-square test.to prevent bacterial growth (Concha et al.
1998). The samples were then frozen and
stored at –80°C (Crecelius et al. 1986).
Collected skin tissue was ﬂash frozen in liquid
nitrogen and stored at –80°C (He et al. 2004).
Blood samples were kept on dry ice before
being transported to our laboratory and kept
frozen at –80°C.
Biomarkers of biological response. We
chose biomarkers of mutation and abnormal
gene expression because they can indicate mol-
ecular changes before the occurrence of cancer
and because of their potential usefulness in
early diagnosis (Klaassen 2001). We used a
standard protocol, and the parameters and
analytical procedures are described in detail in
the citations above. 
Chromosome and DNA damage. Sister
chromatid exchanges (SCEs), chromosomal
aberrations (CAs), and micronuclei (MN)
(Table 1) in peripheral blood were blind counted
(Xie et al. 1999). Spontaneous DNA synthesis
(DS) and unscheduled DNA synthesis (UDS)
were assayed with a liquid scintillation counter
(Beckman Coulter Inc., Fullerton, CA, USA;
Zhang et al. 2000c). DNA–protein cross-links
(DPCs) were measured by an 25I-post labeling
assay (Zhang et al. 2000c). DNA single-strand
breaks (SSBs) were determined by single-cell gel
electrophoresis (SCGE; Zhang et al. 2000b)
and the yield of these breaks was measured
using the DNA COMET assay (Figure 1). 
Expression of P53 and P16 proteins. It is
well known that wild-type P53 protein is a
nuclear phosphoprotein coded by the p53
tumor suppressor gene. If the DNA is dam-
aged, wild-type p53 shuts off cell duplication
and initiates a “suicide system” to kill those cells
with damaged DNA. In contrast, if wild-type
p53 mutates into mutant-type p53, cells with
damaged DNA may enter the S phase prema-
turely and produce CAs (Vogelstein 1990). P16
protein is a known inhibitor of cyclin-depen-
dent kinase 4 (CDK4) that binds to CDK4 in
the G1 phase of the cell cycle to down-regulate
its activity. It inhibits the progression of cells,
especially those with DNA damage from G1 to
S phase. As a result, cell division and growth are
reduced (Serrano 1993; Sherr 1993). 
The immunohistochemical technique is
well established for use in clinical histopatho-
logical diagnosis (Chen et al. 2005; Editorial
Board of the Chinese Journal of Pathology
1996). The expression of P53 and P16 (Table
2) was measured by immunohistochemical
methods in skin tissue samples, most of which
(n = 70) were collected in 1998 (Hong et al.
2000; Hu et al. 2003). The mouse monoclonal
P53 and P16 antibodies and EnVision+
System kit were purchased from Dako (Dako
North America Inc., Carpinteria, CA, USA).
In our study the quantitative data for these per-
centages were transformed into two qualitative
types: positive or negative. For P53 and P16
protein, a subject with more than 1% positive
cells was regarded as positive.
Mutation of p53 and  p16 genes.
Polymerase chain reaction (PCR) single-strand
conformation polymorphism (SSCP), as well
as PCR cloning and sequencing, were used to
detect the mutation of p53 exons 5–8 and p16
exon 2 in 60 peripheral blood samples of sub-
jects (Table 2; Figure 2) collected in 2001 (Pan
et al. 2004;). Point mutation of p53 occurs
mainly in exons 5–8 (Hasegawa et al. 1995;
Vet et al. 1996; Xu et al. 2001); The PCR
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Figure 2 Nucleotide sequence of p53 and p16 . (A) PCR-SSCP analysis of p53 exon 5. Arrow indicates the abnormal band. Lane 1: peripheral blood of healthy
people; lanes 2–4: peripheral blood of patients with arsenicosis. (B) Nucleotide sequence of p53, codon 143 (GTG→GTA). Arrow indicates the mutation site (sam-
ple of arsenicosis patient with precarcinoma: urinary As, 106.29 µg/L; hair As, 21.64 µg/g. (C) Nucleotide sequence of p53, codon 146 (TGG→CGG). Arrow indicates
the mutation site (sample of arsenicosis patient with carcinoma: urinary As, 79.14 µg/L; hair As, 16.42 µg/g). (D) Nucleotide sequence of p53, codon 151
(CCC→TCC). Arrow indicates the mutation site (sample of arsenicosis patients with carcinoma: urinary As, 274.77 µg/L; hair As, 6.18 µg/g). (E) Part of the noncod-
ing strand in p16 exon 2 (sample of arsenicosis patient with hyperkeratosis: urinary As, 111.75 µg/L; hair As, 9.94 µg/g).
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Figure 1. Results of DNA single-strand breaks with
SCGE (400×). Group 1, external control group; group
2, internal control group; group 3, mild arsenicosis
group; group 4, intermediate arsenicosis group;
group 5, severe arsenicosis group (see Table 1 for
urinary and hair As concentrations). primers for p53 were as follows: first pair
of primers—forward, 5´-GTGAGGGG-
GCTCTACACAAG-3´; reverse, 5´-ACCA-
GCGTGTCCAGGAAG-3´; second pair of
primers—forward, 5´-CTTCCTGGACAC-
GCTGGT-3´; reverse, 5´-GTCCTCACCT-
GAGGGACCTT-3´.
Point mutation of p16 gene occurs mainly
in exon 2 (Kamb et al. 1994; Nobori et al.
1994). To obtain a suitable length of segment
for nondenatured polyacrylamide gel, p16 was
amplified by two pair primers, the primer
sequences are are as follows: first pair of
primers—forward, 5´-GTGAGGGGGC-
TCTACACAAG-3´; reverse, 5´-ACCAGC-
GTGTCCAGGAAG-3´; second pair of
primers—forward, 5´-CTTCCTGGACA-
CGCTGGT-3´; reverse, 5´-GTCCTCAC-
CTGAGGGACCTT-3´. The PCR mixture
contained 1 × PCR buffer; dATP,dCTP,
dGTP,dTTP (2 µM each); primers (100
nM); MgCl2 (1.5 mM); Taq DNA polymer
(2 U); and template DNA (200 ng) in a ﬁnal
volume of 50 µL. The PCR program was set
for an initial denaturation at 95°C for 5 min,
35 cycles of denaturation at 94°C for 50 sec,
annealing at 56–65°C (depending on the type
of primer pair used) for 40 sec, extension at
72°C for 50 sec, and ﬁnal extension at 72°C
for 5 min. PCR products were electro-
phoresed on 1.5% agarose gels and observed
under ultraviolet illumination. Five micro-
liters of PCR product was mixed with 5 µL of
denatured solution, which was denatured at
95°C for 5 min and kept on ice for 5 min.
Similarly, a PCR product was added to 8%
nondenatured polyacrylamide gel and elec-
trophoresed with 150 V of constant voltage
for 3 hr. After electrophoresis the gel was
removed and stained with silver.
PCR products were inserted into vector
pMD 18-T, then transformed to the compe-
tent DH5α cell, prepared in LB medium con-
taining AMP100. Plasmid DNA was
extracted using E.Z.N.A Plasmid Miniprep
Kit I (Omega Bio-Tek, Inc., Doraville, GA,
USA); recombinant DNA was screened with
EcoRI, HindIII, and sequenced in Takara
Biotechnology Co. (Dalian, China).
Expression of DNA repair gene. Expressions
of O-6-methylguanine DNA methyltrans-
ferase (MGMT), X-ray repair complementing
defective repair in Chinese hamster cells
1(XRCC1), and mis-match repair gene
(hMSH2) mRNA (Table 3) were analyzed by
in situ hybridization in 61 skin tissue samples.
The samples were from arsenicosis patients
who had undergone surgery in 2001 (Chen
et al. 1999; Zhang et al. 2005). Tissue samples
were analyzed as follows: The sections were
treated with 3% hydrogen peroxide, digested
in proteinase, and prehybridized at 37°C.
Sections were then hybridized overnight and
blocked in paraffin or mineral oil. Mouse
biotin-antidigoxin antibody was applied
for 60 min at 37°C, followed by treatment
with streptavidin–biotin–peroxidase com-
plex (Wuhan Boster Bioengineering Ltd.,
Wuhan, Hubei, China) for 20 min at 37°C,
with biotin–peroxidase for 20 min at 37°C,
and stained with DAB (Wuhan Boster Bio-
engineering Ltd., Wuhan, Hubei, China). The
sections were then refiltered, dehydrated,
cleared and enveloped and visualized using a
microscope. The in situ hybridization kit, DAB
stain kit, and in situ hybridization special
cover-slices were purchased from Wuhan
Boster Biological Engineering Limited Corp.
(Wuhan, China). After in situ hybridization,
positive samples exhibited brownish yellow
inclusions in the cytoplasm. The percentage of
samples was calculated as follow: positive cases
÷ detected cases × 100%. Skin samples from
control groups were taken from nonarsenicosis
patients receiving undergoing other medical
procedures at that hospital at that time. 
Statistical analyses. SPSS (version 11.0,
http://www.spss.com) was used for analysis of
variance (ANOVA), linear correlation and
regression, and the chi-square test. Results
were reported as statistically signiﬁcant when
p < 0.05.
Results
Arsenic exposure and chromosome and DNA
damage. For the external control group, the
average concentrations of urinary As and hair
As were 46 µg/L and 1.6 µg/g, respectively
(Table 1). Urinary As concentrations in the
four exposed groups were 2–3 times that in the
external control group, with p < 0.01.
Compared with the external control group,
hair As concentrations were 3– 5 times that in
the exposed groups, with p < 0.01. It is worth
noting that concentrations of urinary As
(~ 76 µg/L) and hair As (~ 5.4 µg/g) in the
internal control group, that is, subjects without
diagnosable arsenicosis symptoms, were statisti-
cally signiﬁcantly (p < 0.05) lower than those
in the three other groups with mild, moderate,
or severe arsenicosis (Table 1). In addition,
both urinary and hair As concentrations
increased as the degree of arsenicosis increased.
Consistent with the statistically signiﬁcant
difference of As exposure, SCE ratio, which is an
indicator of chromosome damage, was found to
be significantly different in all four exposed
groups compared with the external control
group (p < 0.05 or p < 0.01; Table 1). In addi-
tion, the SCE ratio of the severe arsenicosis
group was higher than that of the internal con-
trol group (p < 0.05; Table 1). CAs were found
to be signiﬁcantly different in the three patients
groups compared with the external control (p <
0.01; Table 1). For MN, only the severe arseni-
cosis group was signiﬁcantly different from the
external control group, internal control group,
and the other two exposed groups (Table 1). 
Unscheduled DNA synthesis increased
gradually with increasing As concentrations in
urine and hair (Table 1), whereas sponta-
neous DNA synthesis showed a dramatic
decrease from approximately 1,150 cpm for
the external control group to approximately
200 and 300 for all four exposed groups.
DNA–protein crosslinks increased with
increasing exposure (Table 1). DPCs in the
internal control group was much higher than
that in the external control group (p < 0.01;
Table 1). It increased remarkably in the mod-
erate and severe groups, compared with the
two control groups and the mild arsenicosis
group (p < 0.05 or p < 0.01; Table 1). DNA
COMET tail length (Figure 1) increased with
increasing As exposure when external control,
nonpatient, mild, moderate, and severe
arsenicosis groups were compared. 
Arsenic exposure and abnormal expressions
of P53 and P16 proteins. In patients with
arsenicosis, skin pathology was classiﬁed accord-
ing to four groups. The positive rate in P53
protein expression was 89% (16/18), 73%
(8/11), 33% (7/21) and 17% (3/18) for the
carcinoma, precarcinoma, hyperkeratosis, and
common pathological changes groups, respec-
tively (Table 2). The high positive rates in the
carcinoma and precarcinoma groups were sta-
tistically different from those in the common
pathological changes and hyperkeratosis groups
(p < 0.05 or p < 0.01; Table 2). The positive
rates of P16 protein expression were 33%
(6/18), 36% (4/11), 68% (15/22), and 79%
(15/19) for the carcinoma, precarcinoma,
hyperkeratosis, and common pathological
changes groups, respectively. The low positive
rate in the carcinoma group was statistically dif-
ferent from those in all other groups; there is
also a signiﬁcant difference between the precar-
cinoma group and the common pathological
changes group (Table 2).
Arsenic exposure and p53 gene mutation.
A striking difference in the p53 mutation fre-
quency was found between the carcinoma
(30%) and precarcinoma groups (17%) com-
pared with the hyperkeratosis (0%) and com-
mon pathological changes (0%) groups (p <
0.05; Table 2). Sequencing p53 identiﬁed the
following mutation types and sites: at codon
143 (GTG→GTA) in two cases, which were
silent mutations; at codon 146 (TGG→CGG)
in one case, resulting in a change from trypto-
phan to arginine in the protein; at codon 151
(CCC→TCC) in two cases, resulting in a
change from proline to serine in the protein
(Table 4; Figure 2). No mutation was found
on p16 exon 2.
Arsenic exposure and abnormal expression
of DNA repair genes. The positive rates of all
DNA repair genes, that is, MGMT, XRCC1,
and hMSH2 mRNA, increased gradually as
the arsenicosis symptoms became milder
(Table 3). The positive rates for MGMT
Zhang et al.
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cinoma, precarcinoma, hyperkeratosis, and
common pathological changes groups, respec-
tively. The carcinoma group displayed statisti-
cally lower positive rates than those of the
common pathological changes group (p <
0.01) and the hyperkeratosis group (p < 0.05)
but not lower than those of the precarcinoma
group. Similar trends were observed for two
other DNA repair genes with respect to As
exposure and symptoms. In this case the low
positive rate of XRCC1 mRNA in the carci-
noma group (27%) was significantly lower
than that for the common pathological
changes group (77%; p < 0.01). The low posi-
tive rate of hMSH2 mRNA (36%) for the car-
cinoma group was not statistically signiﬁcant
from the other groups. 
Discussion
Our results clearly demonstrate that in a popu-
lation exposed to As primarily through con-
sumption of food cooked on coal-burning
unventilated indoor stoves and, to a much
lesser extent, inhalation of the contaminated
air from these stoves, cellular and genetic mate-
rial exhibited changes in most cases consistent
with the As exposure level and symptoms. In
individuals with arsenicosis, DNA was dam-
aged, DNA repair was impaired, and muta-
tions or deletions of p53 and p16 were evident.
Our ﬁndings suggest: a) SCE and CAs are sen-
sitive biomarkers for human chromosome
damage induced by As exposure; b) DNA sin-
gle-strand breaks and DPCs can be used to
monitor DNA damage in populations exposed
to As; c) p53 mutations and p16 deletions were
associated with carcinogenicity due to As expo-
sure; and d) the decrease in DNA repair may
be another important mechanism in arsenicosis
carcinogenicity. 
Biomarkers of As-induced human chromo-
some damage. As-induced chromosome damage
appeared to occur earlier than clinical symp-
toms, as shown by the higher SCE, CA, and
MN values in the exposed groups compared
with the external control group. However,
among the three indicators of chromosome
damage, the MN seems to be the least sensitive
because the difference is not statistically signiﬁ-
cant between the internal control, mild, and
intermediate arsenicosis groups compared with
the external control (Table 1). SCE was found
to be the most sensitive indicator of arsenic
exposure because it was the only biomarker that
displayed a statistically significant difference
between the internal and the external control
groups (Table 1). The CAs was less sensitive
than SCE, but more sensitive than MN
(Table 1). Both mammals and humans exposed
to As had increased frequencies of MN and
CAs, which led to SCE abnormalities (Wilson
et al. 2002). Gurr et al. (1993) found that when
sodium arsenite was used to treat G2-phase
Chinese hamster ovary cells, chromosome con-
densation and breakage were induced, indicat-
ing MN development during interphase. 
Biomarkers of DNA damage. The present
study also showed that SCGE, a sensitive and
common assay, could be used to monitor
DNA damage of populations exposed to As.
Arsenic caused DNA single-strand breaks in
As-exposed populations, with a wide range of
symptoms. The breaks occurred notably earlier
than clinical symptoms (Figure 1). This is con-
sistent with DNA damage determined by
SCGE in human lymphocytes cultured in vitro
with a high concentration of arsenate (0.2–1.5
mmole/L) (Hartmann and Speit 1994).
Furthermore, our results and those from cell
culture studies (Li et al. 2001) showed that As
induced DNA strand breaks and exhibited a
dose–response relationship. 
DNA–protein cross-links are thought to be
important genotoxic lesions induced by envi-
ronmental agents and carcinogens, such as
ultraviolet light (Smith 1962), formaldehyde
(Cosma et al. 1988), and cis- or trans-platinum
(II) diammine dichlorides (Banjar et al. 1984).
Unlike strand breaks and other DNA lesions
that are readily repaired, DPCs are relatively
persistent in the cells (Lei et al.1995; Oleinick
et al.1987). Because of a poor repair capacity,
DNA–protein complexes still exist during
DNA replication, which may cause loss of
important genetic material and even inactivate
tumor suppressor genes (Costa 1991; Lei
et al.1995). In our study, the extent of
DNA–protein cross-linking in the internal
control groups and the three exposed groups
was signifcantly higher than that in the external
control group. There exists a positive relative
relationship between DPC and As poisoning
(Table 1). This suggests that DNA–protein
cross-linking can be used to monitor genetic
damage from As exposure. The formation of
DPCs may be one of the mechanisms that
induces mutation and perhaps cancers in
arsenicosis patients. 
Gene mutations, deletions, and As expo-
sure. p53 mutations were found by PCR-SSCP
in the peripheral blood samples of arsenicosis
patients with precarcinomas and carcinomas.
The mutation frequencies, 17 and 30% for the
precarcinoma and carcinoma groups, respec-
tively, were lower than those reported previ-
ously in tumor tissues of arsenicosis cancer
patients from Taiwan (Hsu et al. 1998; Shibata
et al. 1994). The mutation frequency of p53
exons 5–8 was determined by PCR-SSCP to
be 62%, or in 8 of 13 bladder cancer patients
exposed to As in drinking water from the Black
Foot disease area in Taiwan (Shibata et al.
1994). The mutation frequencies of p53 exons
2–11 were 28.6%–55.6% in skin cancer
patients with Bowen’s disease, basal cell carci-
noma, or squamous cell carcinoma, again from
the Black Foot disease area in Taiwan (Hsu
et al. 1998). These differences in DNA muta-
tion frequencies may be attributed to sample
type: peripheral blood versus tumor tissue.
Several considerations prompted us to investi-
gate DNA samples from peripheral blood:
a) Arsenic is harmful to many organs and can
induce to tumorigenesis. b) Tumorigenesis has
multiple stages and often occurs over a long
period. Monitoring mutations in blood sam-
ples taken over time provides a better opportu-
nity than tissue samples for investigating gene
mutations and tumorigenesis, as tissue samples
are usually more difﬁcult to obtain.
The results of cloning and sequencing
showed that the mutation sites were found at
codon 143 (GTG→GTA) in two cases, which
was a silent mutation; at codon 146 (TGG→
CGG) in one case, which resulted in a change
from tryptophan to arginine in the protein; and
at codon 151 (CCC→TCC) in two cases,
which resulted in a change from proline to ser-
ine in the protein (Figure 2). Hsu et al. (1998)
reported similar results in 16 skin cancer
patients in Taiwan with p53 mutations; 38% of
the mutations were G:C→A:T transitions and
25% silent. The sites of p53 mutations were
mainly exons 5 and 8.
In contrast to p53 mutation, no mutation
was observed for p16 in the peripheral blood
samples of 60 patients, including 5 patients
with p53 mutations, even in the mutation
hotspot exon 2 (Kamb et al. 1994; Nobori et al.
1994). We recognize that mutations of p16
may have been observed if we had analyzed
more samples. Previously, expression of P16
protein was observed in tumor tissues, but in
our study we used peripheral blood samples.
Furthermore, other exon mutations or inactiva-
tion mechanisms such as deletion or methyla-
tion could have inactivated p16 (Lu et al. 2004;
Zhao et al. 2003). We have recently observed
p16 exons 1 and 2 deletions using multi-PCR
in peripheral blood of arsenicosis patients (n =
41) from blood samples obtained in 2004 (Bin
et al. 2006). In noncarcinoma patients (n = 23),
8.7% exhibited p16 deletions. In comparison,
38.9% of carcinoma patients (n = 18) showed
p16 deletions. This difference was statistically
signiﬁcant (p < 0.05). 
DNA synthesis, repair, and As carcinogenic-
ity. Arsenic exposure has a profound impact on
DNA synthesis. This is best illustrated by a
4-fold decrease in the DNA synthesis rate when
the external and internal control groups were
compared (Table 1). The unscheduled DNA
synthesis showed a rather gradual increase as As
exposure increased and symptoms worsened. It
Cellular and genetic damage in arsenicosis patients from Guizhou, China
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Table 4. p53 gene codon mutation types.
Wild- Mutation  Amino  Sample 
Codon type type acids size (n)
143 GTG GTA Silent 2
146 TGG CGG Trp→Arg 1
151 CCC TCC Pro→Ser 2is plausible that As combines with the sulf-
hydryl group of DNA polymerase and repair-
ase, which inhibits the activity of DNA
polymerase and repairase (Meng 1998).
Our study also found that As exposure has
a profound negative impact on DNA repair,
decreasing positive expression for XRCC1,
MGMT, and hMSH2 mRNA with the
increasing severity of skin lesion in arsenicosis
patients (Table 3). The expression product of
XRCC1 is essential in repairing DNA defects
caused by ionizing radiation and alkylating
agents. XRCC1 is involved in base excision
and single-strand break repair (Whitehouse
et al. 2001). Cells with XRCC1 deletion were
found to be sensitive to ionization radiation
and had a high SCE ratio (Zheng 1999).
MGMT is a highly specific repair enzyme
involved in repairing the base at the site of gua-
nine O6 by transferring the alkylated base to
the cysteine residue (Estellen et al. 2000). The
natural expression of MGMT is a key in main-
taining DNA stability of the DNA structure
and repairing DNA alkylation damage.
hMSH2 mRNA can repair a variety of DNA
damage, including alkyl-base mis-matches,
insertions or deletions, and structural abnor-
malities, which lowers the mutation frequency
and maintains stability of DNA structure. 
Our study showed that long-term As
exposure may be associated with chromosome
and DNA damage, gene mutations, deletions,
and alterations in DNA synthesis and repair.
However, the mechanim(s) by which cellular
and genetic damage leads to cancer remains
unclear and further research is needed.
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